Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cytek Biosciences's share price for the quarter that ended in Dec. 2023 was $9.12. Cytek Biosciences's Shares Outstanding (EOP) for the quarter that ended in Dec. 2023 was 130.7 Mil. Therefore, Cytek Biosciences's market cap for the quarter that ended in Dec. 2023 was $1,192.1 Mil.
Cytek Biosciences's quarterly market cap
declined
from Jun. 2023 ($1,164.4 Mil) to Sep. 2023 ($748.2 Mil) but then
increased
from Sep. 2023 ($748.2 Mil) to Dec. 2023 ($1,192.1 Mil).
Cytek Biosciences's annual market cap
declined
from Dec. 2021 ($2,182.8 Mil) to Dec. 2022 ($1,382.1 Mil) and
declined
from Dec. 2022 ($1,382.1 Mil) to Dec. 2023 ($1,192.1 Mil).
Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cytek Biosciences's Enterprise Value for Today is $594.4 Mil.
Cytek Biosciences Market Cap Historical Data
The historical data trend for Cytek Biosciences's Market Cap can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Cytek Biosciences's Market Cap
For the Medical Devices subindustry, Cytek Biosciences's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Cytek Biosciences's Market Cap Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Cytek Biosciences's Market Cap distribution charts can be found below:
* The bar in red indicates where Cytek Biosciences's Market Cap falls into.
Cytek Biosciences Market Cap Calculation
Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.
Cytek Biosciences's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Cytek Biosciences (NAS:CTKB) Market Cap Explanation
Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the companys debt. The real price you pay is the Enterprise Value.
Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.
Cytek Biosciences Market Cap Related Terms
Thank you for viewing the detailed overview of Cytek Biosciences's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.
Cytek Biosciences (Cytek Biosciences) Business Description
Cytek Biosciences Inc is a cell analysis solutions company advancing the next generation of cell analysis tools by leveraging novel technical approaches. Its core instruments, the Aurora and Northern Lights systems, are the first full-spectrum flow cytometers able to deliver high-resolution, high-content, and high-sensitivity cell analysis by utilizing the full spectrum of fluorescence signatures from multiple lasers to distinguish fluorescent tags on single cells. Its FSP platform addresses the inherent limitations of other technologies by providing a higher density of information with greater sensitivity, more flexibility, and increased efficiency, all at a lower cost for performance.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
CTKB has been successfully added to your 